| abstract |
In one aspect, the present invention relates to a composition comprising factor H binding protein (fHBP) and Neisseria Meningitidis non-serogroup B capsular polysaccharide. The present invention further relates to the use of a composition comprising fHBP, such as, for example, to elicit an immune response against serogroup B strains and non-serogroup B strains of Neisseria meningitidis. The compositions and methods described herein relate to administration to humans, including adults, adolescents, young children, and infants. |